Carcinoembryonic Antigen (CEA) with Plasma Specimen
This test measures the level of carcinoembryonic antigen, a protein that may be produced by certain types of cancer cells, including colorectal, pancreatic, and breast cancers. It helps doctors monitor these conditions and track treatment progress.
["CEA levels can indicate cancer presence or spread and guide treatment decisions."]
Key facts at a glance
- LOINC
- 68926-5
- Short code
- CA724PF
- Synonyms
- Cancer Ag72-4 Pcar-aCnc
- Category
- chemistry
- Sample
- serum
- Container
- Sterile, leak-proof container without anticoagulants for pericardial fluid; SST or red-top tube for serum
- Units
- N/A
- Ref low
- 0
- Ref high
- 6
- Critical range
- 0.5 N/A – —
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–99 years
- Method
- Immunoassay (Electrochemiluminescence or Chemiluminescent)
- CPT
- 86316
- SNOMED
- 395787009
- Specimen volume
- 1-2 mL of pericardial fluid or 1 mL of serum
- Stability
- Pericardial fluid: Refrigerated (2-8°C) for up to 7 days; Frozen (-20°C) for up to 6 months. Serum: Room temperature 8 hours, refrigerated 7 days, frozen 6 months.
- Hemolysis max
- 100
- Lipemia max
- 300
- Icterus max
- 50
- TAT
- 24–72 hours
- Order
- routine
What Is Carcinoembryonic Antigen (CEA)?
Carcinoembryonic antigen (CEA) is a protein found in small amounts in healthy people but can rise in people with certain cancers. It is often used as a tumor marker to help diagnose, monitor, or track treatment of cancers like colorectal, pancreatic, or breast cancer. CEA is not specific to any single type of cancer, so it is typically used alongside other tests and clinical findings.
Why Might This Test Be Ordered?
Your doctor may order a CEA test if you have a history of cancer, are at higher risk for certain cancers, or are undergoing treatment for one. It may also be used to check for cancer recurrence or response to treatment. In some cases, it can help monitor conditions like inflammatory bowel disease.
How Is the Test Performed?
A blood sample is taken from a vein, usually in your arm. The blood is then sent to a lab where it is processed to separate plasma. The plasma is analyzed for CEA levels using an immunoassay method, which detects the protein in your blood.
What Do My Results Mean?
Results are reported in nanograms per milliliter (ng/mL). Higher than expected levels may suggest cancer or other conditions, but they are not definitive on their own. Your doctor will interpret results in the context of your medical history, symptoms, and other tests.
Reference range
No established reference range for pericardial fluid. Serum reference: <6.0 U/mL (typically considered normal cutoff in serum). Elevated levels in pericardial fluid may suggest malignant pericardial effusion, particularly from gastric, ovarian, colorectal, or pancreatic origin.N/A
No fasting required. Pericardial fluid is collected via pericardiocentesis by a qualified physician under sterile conditions, typically with echocardiographic guidance.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Clinical Significance:
Short name
Plasma CEA
Frequently asked questions
How often will I need this test?
What are the typical reference ranges?
Can lifestyle changes affect CEA levels?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 17, 2026. · Read our editorial policy